Two Sigma Investments, LP Insulet Corp Call Options Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $214,280 - $303,270	-1,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $1.48 Million - $1.85 Million	-5,800 Reduced 84.06%	1,100 $293,000
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $1.28 Million - $1.51 Million	4,900 Added 245.0%	6,900 $1.96 Million
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $90,208 - $121,624	-400 Reduced 16.67%	2,000 $549,000
Q4 2020 Feb 16, 2021	SELL	$215.97 - $265.89 $107,985 - $132,945	-500 Reduced 17.24%	2,400 $614,000
Q3 2020 Nov 16, 2020	SELL	$192.55 - $236.59 $134,785 - $165,613	-700 Reduced 19.44%	2,900 $686,000
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $63,667 - $89,892	400 Added 12.5%	3,600 $699,000
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $416,032 - $692,608	3,200 New	3,200 $530,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.